Intrials - Latin America Clinical Research
Intrials is a full-service CRO that was founded in 1999 in Brazil. Throughout its 25 years of existence, Intrials opened offices and started operations in other 5 countries in LATAM: Argentina, Chile, Colombia, Mexico and Peru, therefore Intrials has local presence and operations in the 6 main pharmaceutical markets of the region. Intrials has managed over 550 studies so far, and our main expertise is in Oncology, Infectious Diseases/Vaccines, Rare Diseases, Immunology, Cardiology, Dermatology, and Respiratory.
Locations
- South America
Therapeutic Areas
- Bone / Osteoporosis
- Cardiovascular
- CNS
- Dermatology
- Devices and Diagnostics
- Diabetes
- Endocrinology
- Gastroenterology
- Genetic Diseases
- Hematology
- Immunology
- Infectious Diseases
- Metabolic Diseases
- Nephrology
- Neurology
- Obstetrics / Gynecology
- Oncology
- Ophthalmology
- Pain / Anesthesia
- Pediatrics / Neonatology
- Pulmonary
- Rare Disease
- Respiratory
- Rheumatology
- Urology
- Vaccines
- Women's Health
Intrials can provide support in all Study Phases (I, II, III, IV), as well as Study Extension, Post-Studies, Observational / Natural History Studies, and Bioequivalence Studies (in collaboration with BE Centers). All our studies are conducted locally/regionally in Latin America, with Intrials having “boots-on-the-ground” presence in Brazil, Argentina, Chile, Colombia, Peru, and Mexico. We have in-depth knowledge of the regulatory landscape in each of these markets, involving their local agencies: ANVISA (Brazil), ANMAT (Argentina), ISP (Chile), INVIMA (Colombia), DIGEMID (Peru), and COFEPRIS (Mexico). Intrials has extensive experience in conducting multinational clinical trials in LATAM, with at least 60% of all the studies that Intrials has conducted in our history having involved 2 or more of the countries where we operate (Argentina, Brazil, Chile, Colombia, Peru, Mexico).